June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Evaluation of prevalence and risk factors for vitreoretinal involvement in fungemic patients at a tertiary care hospital
Author Affiliations & Notes
  • Karina Esquenazi
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Carl Stanley Wilkins
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Rupak Bhuyan
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Jonathan Levenson
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Robin N Ginsburg
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Alexander Barash
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Avnish Deobhakta
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Gareth M.C. Lema
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Footnotes
    Commercial Relationships   Karina Esquenazi, None; Carl Wilkins, None; Rupak Bhuyan, None; Jonathan Levenson, None; Robin Ginsburg, None; Alexander Barash, None; Avnish Deobhakta, None; Gareth Lema, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1353. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Karina Esquenazi, Carl Stanley Wilkins, Rupak Bhuyan, Jonathan Levenson, Robin N Ginsburg, Alexander Barash, Avnish Deobhakta, Gareth M.C. Lema; Evaluation of prevalence and risk factors for vitreoretinal involvement in fungemic patients at a tertiary care hospital. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1353.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The prevalence of endogenous fungal endophthalmitis varies between studies and the risk factors are poorly defined. This study aims to define prevalence in a large population and identify risk factors warranting ophthalmic evaluation.

Methods : Retrospective review of 291 inpatients with fungemia and a documented ophthalmic evaluation (January 2015-September 2019) was performed. We reviewed the presence of visual complaint, number and duration of positive blood cultures, history of gastrointestinal (GI) surgery in preceding 6 months, solid organ transplant, human immunodeficiency virus (HIV) infection, diabetes mellitus (DM), intravenous (IV) drug use, and central venous access. Student’s t-test and chi-squared statistical analysis were performed.

Results : 291 patients were included; 6 had vitreoretinal involvement and 2 required intravitreal antifungal injection. Those with vitreoretinal involvement had an average of 3 positive cultures over 0.69 weeks, while those with normal findings averaged 2.85 positive cultures over 0.59 weeks (p= 0.89, and 0.80, respectively). History of GI surgery, organ transplant, immunocompromised state, DM, IV drug use, and central venous catheter were not found to be significant. However, 33.3% of the endophthalmitis group had a visual complaint compared to 4.20% of the non-endophthalmitis group (p<0.001). When grouped together, visual complaints, positive blood cultures for 3 or more days, and history of recent GI surgery were significant predictors of ocular involvement. For patients without any of these 3 major risk factors, the negative predictive value was 98.7%.

Conclusions : Patients who have visual complaints at the time of positive fungal blood culture are significantly more likely to have a positive screening examination. No other individual variables were found to be predictive of a positive screening examination. A positive examination is exceedingly rare in patients not meeting risk criteria (major factors) for screening. Serious consideration of replacing the current practice of uniform ophthalmic screening among fungemic patients with examination limited to those meeting major criteria is recommended.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×